×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 9: SAE Case Study
Session Chair(s)
Mark Vieder, MBA, RPh
Vice President, Drug Safety and Pharmacovigilance
Biorasi, LLC, United States
Small groups will discuss fictional Serious Adverse Event reports from clinical trials and determine seriousness, expectedness, and causality.
Have an account?